Henderson Jane - Insider Non-Derivative Transactions at Apogee Therapeutics, Inc. (APGE) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 19, 2025, Henderson Jane's relationship to Apogee Therapeutics, Inc. (APGE) is Officer (Chief Financial Officer), and currently has 193,371 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other APGE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Henderson Jane - Insider Non-Derivative Transactions of APGE Common Stock

Henderson Jane - Insider Non-Derivative Transactions at APGE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 20, 2025	Sell -- (Common Stock)	1500	80	193371
Dec 5, 2025	Sell -- (Common Stock)	1500	75	194871
Nov 26, 2025	Sell -- (Common Stock)	1500	70	196371
Nov 15, 2025	Sell -- (Common Stock)	2000	65	197871
Nov 12, 2025	Sell -- (Common Stock)	1000	60	199871
Aug 24, 2024	Sell -- (Common Stock)	6000	48.26	200871